[{"edinetCode":"E00923","endDate":"2017\/3\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":5511.0,"averageTemporaryStaff":866.0,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":126953000.0,"sharesOwendPercent":0.3857,"outstandingShares":null,"numberOfSubsidiary":38.0,"bps":1638.46,"equityRatio":0.779,"cashAndCashEquivalents":149324000000.0,"assets":670271000000.0,"currentAssets":343384000000.0,"fixedAsset":326886000000.0,"tangibleFixedAssets":78788000000.0,"intangibleFixedAssets":91125000000.0,"investmentAndOtherAssets":156972000000.0,"liabilities":144059000000.0,"currentLiabilities":90595000000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":53464000000.0,"bonds":20054000000.0,"convertibleBond":null,"commercialPaper":null,"longTermDebts":10000000000.0,"netAsset":526211000000.0,"capitalStock":522445000000.0,"capital":21279000000.0,"capitalSurplus":20227000000.0,"accumulatedEarnings":508049000000.0,"treasuryStock":-27110000000.0,"valuationAndConversionAdjustments":-125000000.0,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":338890000000.0,"costOfSales":77777000000.0,"grossProfit":261113000000.0,"sgaExpenses":152934000000.0,"salaryAndBenefit":25759000000.0,"depreciationAndSGA":null,"RDExpenses":59907000000.0,"operatingIncome":108178000000.0,"nonOperatingIncome":19312000000.0,"nonOperatingExpenses":4459000000.0,"interestExpense":220000000.0,"ordinaryProfit":123031000000.0,"extraordinaryGain":2182000000.0,"extraordinaryLoss":2517000000.0,"incomeBeforeTax":122695000000.0,"incomeTaxes":39084000000.0,"netIncome":83610000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":83879000000.0,"comprehensiveIncome":69398000000.0,"eps":259.88,"dilutedEps":255.87,"dividendPerShare":null,"per":22.12,"roe":0.1626,"cashFlowFromOperatingActivities":111903000000.0,"depreciationAndCashflowFromOperatingActivities":13362000000.0,"cashFlowFromInvestingActivities":-31643000000.0,"cashFlowFromFinancialActivities":-57411000000.0,"changesInCashAndCashEquivalents":21580000000.0,"列1":"asr","submitDate":"2017\/6\/22","stockCode":4507,"accountingYear":"第152期（自　平成28年４月１日　至　平成29年３月31日）","accountingYearStart":"2016\/4\/1","accountingYearEnd":"2017\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E00923","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":21279,"settlementDate":"2022\/3\/31","submitterName":"塩野義製薬株式会社","submitterNameEnglish":"Shionogi & Co.,Ltd.","submitterNameKana":"シオノギセイヤクカブシキガイシャ","location":"大阪市中央区道修町３丁目１番８号","industory":"医薬品","corporateNumber":9120000000000.0},{"edinetCode":"E00923","endDate":"2018\/3\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":5120.0,"averageTemporaryStaff":1149.0,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":124230000.0,"sharesOwendPercent":0.3951,"outstandingShares":null,"numberOfSubsidiary":44.0,"bps":1911.36,"equityRatio":0.832,"cashAndCashEquivalents":172400000000.0,"assets":722500000000.0,"currentAssets":391266000000.0,"fixedAsset":331233000000.0,"tangibleFixedAssets":75956000000.0,"intangibleFixedAssets":75060000000.0,"investmentAndOtherAssets":180216000000.0,"liabilities":117659000000.0,"currentLiabilities":72566000000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":10000000000.0,"fixedLiabilities":45092000000.0,"bonds":18491000000.0,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":604840000000.0,"capitalStock":579257000000.0,"capital":21279000000.0,"capitalSurplus":20227000000.0,"accumulatedEarnings":574392000000.0,"treasuryStock":-36641000000.0,"valuationAndConversionAdjustments":21589000000.0,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":344667000000.0,"costOfSales":73911000000.0,"grossProfit":270756000000.0,"sgaExpenses":155537000000.0,"salaryAndBenefit":25379000000.0,"depreciationAndSGA":null,"RDExpenses":59945000000.0,"operatingIncome":115219000000.0,"nonOperatingIncome":28326000000.0,"nonOperatingExpenses":4852000000.0,"interestExpense":557000000.0,"ordinaryProfit":138692000000.0,"extraordinaryGain":null,"extraordinaryLoss":1314000000.0,"incomeBeforeTax":137378000000.0,"incomeTaxes":28589000000.0,"netIncome":108788000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":108866000000.0,"comprehensiveIncome":130573000000.0,"eps":342.71,"dilutedEps":337.43,"dividendPerShare":null,"per":16.02,"roe":0.1939,"cashFlowFromOperatingActivities":129790000000.0,"depreciationAndCashflowFromOperatingActivities":15972000000.0,"cashFlowFromInvestingActivities":-51238000000.0,"cashFlowFromFinancialActivities":-53893000000.0,"changesInCashAndCashEquivalents":23076000000.0,"列1":"asr","submitDate":"2018\/6\/20","stockCode":4507,"accountingYear":"第153期（自　2017年４月１日　至　2018年３月31日）","accountingYearStart":"2017\/4\/1","accountingYearEnd":"2018\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E00923","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":21279,"settlementDate":"2022\/3\/31","submitterName":"塩野義製薬株式会社","submitterNameEnglish":"Shionogi & Co.,Ltd.","submitterNameKana":"シオノギセイヤクカブシキガイシャ","location":"大阪市中央区道修町３丁目１番８号","industory":"医薬品","corporateNumber":9120000000000.0},{"edinetCode":"E00923","endDate":"2019\/3\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":5233.0,"averageTemporaryStaff":1071.0,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":118549000.0,"sharesOwendPercent":0.3808,"outstandingShares":null,"numberOfSubsidiary":47.0,"bps":2144.33,"equityRatio":0.857,"cashAndCashEquivalents":195800000000.0,"assets":778741000000.0,"currentAssets":461743000000.0,"fixedAsset":316997000000.0,"tangibleFixedAssets":74653000000.0,"intangibleFixedAssets":54769000000.0,"investmentAndOtherAssets":187574000000.0,"liabilities":106311000000.0,"currentLiabilities":89107000000.0,"shorTermDept":null,"currentPortionOfBonds":920000000.0,"currentPortionOfLongTermDebt":null,"fixedLiabilities":17203000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":672429000000.0,"capitalStock":652371000000.0,"capital":21279000000.0,"capitalSurplus":20512000000.0,"accumulatedEarnings":639461000000.0,"treasuryStock":-28882000000.0,"valuationAndConversionAdjustments":15130000000.0,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":363721000000.0,"costOfSales":54880000000.0,"grossProfit":308841000000.0,"sgaExpenses":170303000000.0,"salaryAndBenefit":24845000000.0,"depreciationAndSGA":null,"RDExpenses":68325000000.0,"operatingIncome":138537000000.0,"nonOperatingIncome":33256000000.0,"nonOperatingExpenses":5218000000.0,"interestExpense":581000000.0,"ordinaryProfit":166575000000.0,"extraordinaryGain":20854000000.0,"extraordinaryLoss":17086000000.0,"incomeBeforeTax":170343000000.0,"incomeTaxes":37037000000.0,"netIncome":133306000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":132759000000.0,"comprehensiveIncome":126626000000.0,"eps":424.31,"dilutedEps":420.67,"dividendPerShare":null,"per":16.15,"roe":0.2093,"cashFlowFromOperatingActivities":145684000000.0,"depreciationAndCashflowFromOperatingActivities":16479000000.0,"cashFlowFromInvestingActivities":-36349000000.0,"cashFlowFromFinancialActivities":-87011000000.0,"changesInCashAndCashEquivalents":23399000000.0,"列1":"asr","submitDate":"2019\/6\/18","stockCode":4507,"accountingYear":"第154期（自　2018年４月１日　至　2019年３月31日）","accountingYearStart":"2018\/4\/1","accountingYearEnd":"2019\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E00923","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":21279,"settlementDate":"2022\/3\/31","submitterName":"塩野義製薬株式会社","submitterNameEnglish":"Shionogi & Co.,Ltd.","submitterNameKana":"シオノギセイヤクカブシキガイシャ","location":"大阪市中央区道修町３丁目１番８号","industory":"医薬品","corporateNumber":9120000000000.0},{"edinetCode":"E00923","endDate":"2019\/6\/30","Report abbreviation_x":"q1r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.884,"cashAndCashEquivalents":null,"assets":754631000000.0,"currentAssets":443535000000.0,"fixedAsset":311096000000.0,"tangibleFixedAssets":74166000000.0,"intangibleFixedAssets":53053000000.0,"investmentAndOtherAssets":183875000000.0,"liabilities":82677000000.0,"currentLiabilities":64855000000.0,"shorTermDept":null,"currentPortionOfBonds":900000000.0,"currentPortionOfLongTermDebt":null,"fixedLiabilities":17822000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":671954000000.0,"capitalStock":661332000000.0,"capital":21279000000.0,"capitalSurplus":20512000000.0,"accumulatedEarnings":648183000000.0,"treasuryStock":-28643000000.0,"valuationAndConversionAdjustments":5760000000.0,"Report abbreviation_y":"q1r","context_y":"当四半期累計期間連結期間","Sales":79225000000.0,"costOfSales":12735000000.0,"grossProfit":66489000000.0,"sgaExpenses":37532000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":28957000000.0,"nonOperatingIncome":5861000000.0,"nonOperatingExpenses":2417000000.0,"interestExpense":22000000.0,"ordinaryProfit":32401000000.0,"extraordinaryGain":null,"extraordinaryLoss":530000000.0,"incomeBeforeTax":31871000000.0,"incomeTaxes":7504000000.0,"netIncome":24366000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":24418000000.0,"comprehensiveIncome":15071000000.0,"eps":78.43,"dilutedEps":78.33,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q1r","submitDate":"2019\/8\/7","stockCode":4507,"accountingYear":null,"accountingYearStart":"2019\/4\/1","accountingYearEnd":"2020\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E00923","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":21279,"settlementDate":"2022\/3\/31","submitterName":"塩野義製薬株式会社","submitterNameEnglish":"Shionogi & Co.,Ltd.","submitterNameKana":"シオノギセイヤクカブシキガイシャ","location":"大阪市中央区道修町３丁目１番８号","industory":"医薬品","corporateNumber":9120000000000.0},{"edinetCode":"E00923","endDate":"2019\/9\/30","Report abbreviation_x":"q2r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":122148000.0,"sharesOwendPercent":0.3922,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.883,"cashAndCashEquivalents":240332000000.0,"assets":778467000000.0,"currentAssets":480300000000.0,"fixedAsset":298167000000.0,"tangibleFixedAssets":75045000000.0,"intangibleFixedAssets":50593000000.0,"investmentAndOtherAssets":172528000000.0,"liabilities":86329000000.0,"currentLiabilities":69511000000.0,"shorTermDept":null,"currentPortionOfBonds":740000000.0,"currentPortionOfLongTermDebt":null,"fixedLiabilities":16818000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":692137000000.0,"capitalStock":688890000000.0,"capital":21279000000.0,"capitalSurplus":20512000000.0,"accumulatedEarnings":675364000000.0,"treasuryStock":-28266000000.0,"valuationAndConversionAdjustments":-1451000000.0,"Report abbreviation_y":"q2r","context_y":"当四半期累計期間連結期間","Sales":160877000000.0,"costOfSales":27898000000.0,"grossProfit":132978000000.0,"sgaExpenses":74816000000.0,"salaryAndBenefit":10673000000.0,"depreciationAndSGA":null,"RDExpenses":22973000000.0,"operatingIncome":58161000000.0,"nonOperatingIncome":9949000000.0,"nonOperatingExpenses":2805000000.0,"interestExpense":51000000.0,"ordinaryProfit":65305000000.0,"extraordinaryGain":2672000000.0,"extraordinaryLoss":590000000.0,"incomeBeforeTax":67386000000.0,"incomeTaxes":15814000000.0,"netIncome":51572000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":51616000000.0,"comprehensiveIncome":34893000000.0,"eps":165.78,"dilutedEps":165.56,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":61141000000.0,"depreciationAndCashflowFromOperatingActivities":8220000000.0,"cashFlowFromInvestingActivities":611000000.0,"cashFlowFromFinancialActivities":-15765000000.0,"changesInCashAndCashEquivalents":44531000000.0,"列1":"q2r","submitDate":"2019\/11\/11","stockCode":4507,"accountingYear":null,"accountingYearStart":"2019\/4\/1","accountingYearEnd":"2020\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E00923","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":21279,"settlementDate":"2022\/3\/31","submitterName":"塩野義製薬株式会社","submitterNameEnglish":"Shionogi & Co.,Ltd.","submitterNameKana":"シオノギセイヤクカブシキガイシャ","location":"大阪市中央区道修町３丁目１番８号","industory":"医薬品","corporateNumber":9120000000000.0},{"edinetCode":"E00923","endDate":"2019\/12\/31","Report abbreviation_x":"q3r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.9,"cashAndCashEquivalents":null,"assets":765439000000.0,"currentAssets":461102000000.0,"fixedAsset":304336000000.0,"tangibleFixedAssets":75605000000.0,"intangibleFixedAssets":56648000000.0,"investmentAndOtherAssets":172082000000.0,"liabilities":75962000000.0,"currentLiabilities":59359000000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":16602000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":689477000000.0,"capitalStock":683321000000.0,"capital":21279000000.0,"capitalSurplus":21298000000.0,"accumulatedEarnings":698751000000.0,"treasuryStock":-58008000000.0,"valuationAndConversionAdjustments":5575000000.0,"Report abbreviation_y":"q3r","context_y":"当四半期累計期間連結期間","Sales":253514000000.0,"costOfSales":40994000000.0,"grossProfit":212519000000.0,"sgaExpenses":113270000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":99249000000.0,"nonOperatingIncome":18848000000.0,"nonOperatingExpenses":3198000000.0,"interestExpense":75000000.0,"ordinaryProfit":114899000000.0,"extraordinaryGain":5255000000.0,"extraordinaryLoss":696000000.0,"incomeBeforeTax":119459000000.0,"incomeTaxes":28650000000.0,"netIncome":90808000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":90844000000.0,"comprehensiveIncome":81044000000.0,"eps":292.78,"dilutedEps":292.42,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q3r","submitDate":"2020\/2\/10","stockCode":4507,"accountingYear":null,"accountingYearStart":"2019\/4\/1","accountingYearEnd":"2020\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E00923","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":21279,"settlementDate":"2022\/3\/31","submitterName":"塩野義製薬株式会社","submitterNameEnglish":"Shionogi & Co.,Ltd.","submitterNameKana":"シオノギセイヤクカブシキガイシャ","location":"大阪市中央区道修町３丁目１番８号","industory":"医薬品","corporateNumber":9120000000000.0},{"edinetCode":"E00923","endDate":"2020\/3\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":5222.0,"averageTemporaryStaff":1022.0,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":126337000.0,"sharesOwendPercent":0.4158,"outstandingShares":null,"numberOfSubsidiary":null,"bps":2248.69,"equityRatio":0.883,"cashAndCashEquivalents":208861000000.0,"assets":871526000000.0,"currentAssets":516026000000.0,"fixedAsset":null,"tangibleFixedAssets":71350000000.0,"intangibleFixedAssets":null,"investmentAndOtherAssets":null,"liabilities":106915000000.0,"currentLiabilities":81119000000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":null,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":null,"capitalStock":null,"capital":21279000000.0,"capitalSurplus":20432000000.0,"accumulatedEarnings":708291000000.0,"treasuryStock":-77292000000.0,"valuationAndConversionAdjustments":null,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":null,"costOfSales":56782000000.0,"grossProfit":null,"sgaExpenses":95094000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":null,"nonOperatingIncome":null,"nonOperatingExpenses":null,"interestExpense":null,"ordinaryProfit":null,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":null,"incomeTaxes":null,"netIncome":null,"netIncomeAttributableToOwnersOfTheParentCompany":null,"comprehensiveIncome":94497000000.0,"eps":392.8,"dilutedEps":392.38,"dividendPerShare":null,"per":13.5,"roe":0.18,"cashFlowFromOperatingActivities":131940000000.0,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":-29144000000.0,"cashFlowFromFinancialActivities":-88174000000.0,"changesInCashAndCashEquivalents":null,"列1":"asr","submitDate":"2020\/6\/24","stockCode":4507,"accountingYear":"第155期（自　2019年４月１日　至　2020年３月31日）","accountingYearStart":"2019\/4\/1","accountingYearEnd":"2020\/3\/31","accountingStandards":"IFRS","consolidatedAccounting":true,"edinetCode2":"E00923","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":21279,"settlementDate":"2022\/3\/31","submitterName":"塩野義製薬株式会社","submitterNameEnglish":"Shionogi & Co.,Ltd.","submitterNameKana":"シオノギセイヤクカブシキガイシャ","location":"大阪市中央区道修町３丁目１番８号","industory":"医薬品","corporateNumber":9120000000000.0},{"edinetCode":"E00923","endDate":"2020\/6\/30","Report abbreviation_x":"q1r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":null,"cashAndCashEquivalents":null,"assets":864573000000.0,"currentAssets":496522000000.0,"fixedAsset":null,"tangibleFixedAssets":69973000000.0,"intangibleFixedAssets":null,"investmentAndOtherAssets":null,"liabilities":96083000000.0,"currentLiabilities":70978000000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":null,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":null,"capitalStock":null,"capital":21279000000.0,"capitalSurplus":20734000000.0,"accumulatedEarnings":682550000000.0,"treasuryStock":-45875000000.0,"valuationAndConversionAdjustments":null,"Report abbreviation_y":"q1r","context_y":"当四半期累計期間連結期間","Sales":null,"costOfSales":11488000000.0,"grossProfit":null,"sgaExpenses":20866000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":null,"nonOperatingIncome":null,"nonOperatingExpenses":null,"interestExpense":null,"ordinaryProfit":null,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":null,"incomeTaxes":null,"netIncome":null,"netIncomeAttributableToOwnersOfTheParentCompany":null,"comprehensiveIncome":null,"eps":null,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":14285000000.0,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":-34034000000.0,"cashFlowFromFinancialActivities":-18582000000.0,"changesInCashAndCashEquivalents":null,"列1":"q1r","submitDate":"2020\/8\/13","stockCode":4507,"accountingYear":null,"accountingYearStart":"2020\/4\/1","accountingYearEnd":"2021\/3\/31","accountingStandards":"IFRS","consolidatedAccounting":true,"edinetCode2":"E00923","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":21279,"settlementDate":"2022\/3\/31","submitterName":"塩野義製薬株式会社","submitterNameEnglish":"Shionogi & Co.,Ltd.","submitterNameKana":"シオノギセイヤクカブシキガイシャ","location":"大阪市中央区道修町３丁目１番８号","industory":"医薬品","corporateNumber":9120000000000.0},{"edinetCode":"E00923","endDate":"2020\/9\/30","Report abbreviation_x":"q2r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":129617000.0,"sharesOwendPercent":0.4177,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":null,"cashAndCashEquivalents":null,"assets":930846000000.0,"currentAssets":562384000000.0,"fixedAsset":null,"tangibleFixedAssets":70350000000.0,"intangibleFixedAssets":null,"investmentAndOtherAssets":null,"liabilities":94329000000.0,"currentLiabilities":72077000000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":null,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":null,"capitalStock":null,"capital":21279000000.0,"capitalSurplus":20734000000.0,"accumulatedEarnings":707718000000.0,"treasuryStock":-7982000000.0,"valuationAndConversionAdjustments":null,"Report abbreviation_y":"q2r","context_y":"当四半期累計期間連結期間","Sales":null,"costOfSales":22857000000.0,"grossProfit":null,"sgaExpenses":43157000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":null,"nonOperatingIncome":null,"nonOperatingExpenses":null,"interestExpense":null,"ordinaryProfit":null,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":null,"incomeTaxes":null,"netIncome":null,"netIncomeAttributableToOwnersOfTheParentCompany":null,"comprehensiveIncome":null,"eps":null,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":46978000000.0,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":-28264000000.0,"cashFlowFromFinancialActivities":14062000000.0,"changesInCashAndCashEquivalents":null,"列1":"q2r","submitDate":"2020\/11\/12","stockCode":4507,"accountingYear":null,"accountingYearStart":"2020\/4\/1","accountingYearEnd":"2021\/3\/31","accountingStandards":"IFRS","consolidatedAccounting":true,"edinetCode2":"E00923","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":21279,"settlementDate":"2022\/3\/31","submitterName":"塩野義製薬株式会社","submitterNameEnglish":"Shionogi & Co.,Ltd.","submitterNameKana":"シオノギセイヤクカブシキガイシャ","location":"大阪市中央区道修町３丁目１番８号","industory":"医薬品","corporateNumber":9120000000000.0},{"edinetCode":"E00923","endDate":"2020\/12\/31","Report abbreviation_x":"q3r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":null,"cashAndCashEquivalents":null,"assets":945726000000.0,"currentAssets":544126000000.0,"fixedAsset":null,"tangibleFixedAssets":74770000000.0,"intangibleFixedAssets":null,"investmentAndOtherAssets":null,"liabilities":95458000000.0,"currentLiabilities":72396000000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":null,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":null,"capitalStock":null,"capital":21279000000.0,"capitalSurplus":21326000000.0,"accumulatedEarnings":728684000000.0,"treasuryStock":-28422000000.0,"valuationAndConversionAdjustments":null,"Report abbreviation_y":"q3r","context_y":"当四半期累計期間連結期間","Sales":null,"costOfSales":35947000000.0,"grossProfit":null,"sgaExpenses":66232000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":null,"nonOperatingIncome":null,"nonOperatingExpenses":null,"interestExpense":null,"ordinaryProfit":null,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":null,"incomeTaxes":null,"netIncome":null,"netIncomeAttributableToOwnersOfTheParentCompany":null,"comprehensiveIncome":null,"eps":null,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":58640000000.0,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":-47973000000.0,"cashFlowFromFinancialActivities":-13342000000.0,"changesInCashAndCashEquivalents":null,"列1":"q3r","submitDate":"2021\/2\/10","stockCode":4507,"accountingYear":null,"accountingYearStart":"2020\/4\/1","accountingYearEnd":"2021\/3\/31","accountingStandards":"IFRS","consolidatedAccounting":true,"edinetCode2":"E00923","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":21279,"settlementDate":"2022\/3\/31","submitterName":"塩野義製薬株式会社","submitterNameEnglish":"Shionogi & Co.,Ltd.","submitterNameKana":"シオノギセイヤクカブシキガイシャ","location":"大阪市中央区道修町３丁目１番８号","industory":"医薬品","corporateNumber":9120000000000.0},{"edinetCode":"E00923","endDate":"2021\/3\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":5485.0,"averageTemporaryStaff":1016.0,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":131443000.0,"sharesOwendPercent":0.436,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":null,"cashAndCashEquivalents":null,"assets":998992000000.0,"currentAssets":556238000000.0,"fixedAsset":null,"tangibleFixedAssets":90883000000.0,"intangibleFixedAssets":null,"investmentAndOtherAssets":null,"liabilities":134442000000.0,"currentLiabilities":100180000000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":null,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":null,"capitalStock":null,"capital":21279000000.0,"capitalSurplus":13733000000.0,"accumulatedEarnings":752248000000.0,"treasuryStock":-57989000000.0,"valuationAndConversionAdjustments":null,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":null,"costOfSales":52523000000.0,"grossProfit":null,"sgaExpenses":91902000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":null,"nonOperatingIncome":null,"nonOperatingExpenses":null,"interestExpense":null,"ordinaryProfit":null,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":null,"incomeTaxes":null,"netIncome":null,"netIncomeAttributableToOwnersOfTheParentCompany":null,"comprehensiveIncome":null,"eps":null,"dilutedEps":null,"dividendPerShare":null,"per":16.3,"roe":null,"cashFlowFromOperatingActivities":109039000000.0,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":-5261000000.0,"cashFlowFromFinancialActivities":-43891000000.0,"changesInCashAndCashEquivalents":null,"列1":"asr","submitDate":"2021\/6\/23","stockCode":4507,"accountingYear":"第156期（自　2020年４月１日　至　2021年３月31日）","accountingYearStart":"2020\/4\/1","accountingYearEnd":"2021\/3\/31","accountingStandards":"IFRS","consolidatedAccounting":true,"edinetCode2":"E00923","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":21279,"settlementDate":"2022\/3\/31","submitterName":"塩野義製薬株式会社","submitterNameEnglish":"Shionogi & Co.,Ltd.","submitterNameKana":"シオノギセイヤクカブシキガイシャ","location":"大阪市中央区道修町３丁目１番８号","industory":"医薬品","corporateNumber":9120000000000.0},{"edinetCode":"E00923","endDate":"2021\/6\/30","Report abbreviation_x":"q1r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":null,"cashAndCashEquivalents":null,"assets":1000350000000.0,"currentAssets":558186000000.0,"fixedAsset":null,"tangibleFixedAssets":91601000000.0,"intangibleFixedAssets":null,"investmentAndOtherAssets":null,"liabilities":118458000000.0,"currentLiabilities":86154000000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":null,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":null,"capitalStock":null,"capital":21279000000.0,"capitalSurplus":14531000000.0,"accumulatedEarnings":768358000000.0,"treasuryStock":-57990000000.0,"valuationAndConversionAdjustments":null,"Report abbreviation_y":"q1r","context_y":"当四半期累計期間連結期間","Sales":null,"costOfSales":12331000000.0,"grossProfit":null,"sgaExpenses":21750000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":null,"nonOperatingIncome":null,"nonOperatingExpenses":null,"interestExpense":null,"ordinaryProfit":null,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":null,"incomeTaxes":null,"netIncome":null,"netIncomeAttributableToOwnersOfTheParentCompany":null,"comprehensiveIncome":null,"eps":null,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":20266000000.0,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":-73413000000.0,"cashFlowFromFinancialActivities":-17457000000.0,"changesInCashAndCashEquivalents":null,"列1":"q1r","submitDate":"2021\/8\/10","stockCode":4507,"accountingYear":null,"accountingYearStart":"2021\/4\/1","accountingYearEnd":"2022\/3\/31","accountingStandards":"IFRS","consolidatedAccounting":true,"edinetCode2":"E00923","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":21279,"settlementDate":"2022\/3\/31","submitterName":"塩野義製薬株式会社","submitterNameEnglish":"Shionogi & Co.,Ltd.","submitterNameKana":"シオノギセイヤクカブシキガイシャ","location":"大阪市中央区道修町３丁目１番８号","industory":"医薬品","corporateNumber":9120000000000.0},{"edinetCode":"E00923","endDate":"2021\/9\/30","Report abbreviation_x":"q2r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":143036000.0,"sharesOwendPercent":0.4744,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":null,"cashAndCashEquivalents":null,"assets":1020450000000.0,"currentAssets":581922000000.0,"fixedAsset":null,"tangibleFixedAssets":95024000000.0,"intangibleFixedAssets":null,"investmentAndOtherAssets":null,"liabilities":121554000000.0,"currentLiabilities":89861000000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":null,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":null,"capitalStock":null,"capital":21279000000.0,"capitalSurplus":14588000000.0,"accumulatedEarnings":789134000000.0,"treasuryStock":-57851000000.0,"valuationAndConversionAdjustments":null,"Report abbreviation_y":"q2r","context_y":"当四半期累計期間連結期間","Sales":null,"costOfSales":26984000000.0,"grossProfit":null,"sgaExpenses":44248000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":null,"nonOperatingIncome":null,"nonOperatingExpenses":null,"interestExpense":null,"ordinaryProfit":null,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":null,"incomeTaxes":null,"netIncome":null,"netIncomeAttributableToOwnersOfTheParentCompany":null,"comprehensiveIncome":null,"eps":null,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":55008000000.0,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":-76183000000.0,"cashFlowFromFinancialActivities":-18324000000.0,"changesInCashAndCashEquivalents":-40114000000.0,"列1":"q2r","submitDate":"2021\/11\/11","stockCode":4507,"accountingYear":null,"accountingYearStart":"2021\/4\/1","accountingYearEnd":"2022\/3\/31","accountingStandards":"IFRS","consolidatedAccounting":true,"edinetCode2":"E00923","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":21279,"settlementDate":"2022\/3\/31","submitterName":"塩野義製薬株式会社","submitterNameEnglish":"Shionogi & Co.,Ltd.","submitterNameKana":"シオノギセイヤクカブシキガイシャ","location":"大阪市中央区道修町３丁目１番８号","industory":"医薬品","corporateNumber":9120000000000.0},{"edinetCode":"E00923","endDate":"2021\/12\/31","Report abbreviation_x":"q3r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":null,"cashAndCashEquivalents":null,"assets":1038900000000.0,"currentAssets":586677000000.0,"fixedAsset":null,"tangibleFixedAssets":102442000000.0,"intangibleFixedAssets":null,"investmentAndOtherAssets":null,"liabilities":126588000000.0,"currentLiabilities":94493000000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":null,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":null,"capitalStock":null,"capital":21279000000.0,"capitalSurplus":14683000000.0,"accumulatedEarnings":790909000000.0,"treasuryStock":-57853000000.0,"valuationAndConversionAdjustments":null,"Report abbreviation_y":"q3r","context_y":"当四半期累計期間連結期間","Sales":null,"costOfSales":39853000000.0,"grossProfit":null,"sgaExpenses":66542000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":null,"nonOperatingIncome":null,"nonOperatingExpenses":null,"interestExpense":null,"ordinaryProfit":null,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":null,"incomeTaxes":null,"netIncome":null,"netIncomeAttributableToOwnersOfTheParentCompany":null,"comprehensiveIncome":null,"eps":null,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":76709000000.0,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":-117964000000.0,"cashFlowFromFinancialActivities":-35733000000.0,"changesInCashAndCashEquivalents":-74890000000.0,"列1":"q3r","submitDate":"2022\/2\/10","stockCode":4507,"accountingYear":null,"accountingYearStart":"2021\/4\/1","accountingYearEnd":"2022\/3\/31","accountingStandards":"IFRS","consolidatedAccounting":true,"edinetCode2":"E00923","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":21279,"settlementDate":"2022\/3\/31","submitterName":"塩野義製薬株式会社","submitterNameEnglish":"Shionogi & Co.,Ltd.","submitterNameKana":"シオノギセイヤクカブシキガイシャ","location":"大阪市中央区道修町３丁目１番８号","industory":"医薬品","corporateNumber":9120000000000.0}]